메뉴 건너뛰기




Volumn 12, Issue 3, 2016, Pages e281-e288

Physician experience and attitudes toward addressing the cost of cancer care

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER THERAPY; COST BENEFIT ANALYSIS; FEMALE; HUMAN; MALE; MEDICAL ONCOLOGIST; PATIENT EDUCATION; PHYSICIAN ATTITUDE; RADIATION ONCOLOGIST; SELECTION BIAS; SELF EVALUATION; SOCIETY; SURGICAL ONCOLOGIST; WORK EXPERIENCE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; ECONOMICS; HEALTH CARE COST; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; NEOPLASMS; ONCOLOGY; PHYSICIAN;

EID: 84962613004     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2015.007401     Document Type: Article
Times cited : (68)

References (17)
  • 2
    • 84907082705 scopus 로고    scopus 로고
    • Innovative payment models and measurement for cancer therapy
    • Newcomer LN: Innovative payment models and measurement for cancer therapy. J Oncol Pract 10:187-189, 2014
    • (2014) J Oncol Pract , vol.10 , pp. 187-189
    • Newcomer, L.N.1
  • 3
    • 84919711795 scopus 로고    scopus 로고
    • Debating the oncologist's role in defining the value of cancer care: We have a duty to society
    • Jagsi R: Debating the oncologist's role in defining the value of cancer care: We have a duty to society. J Clin Oncol 32:4035-4038, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 4035-4038
    • Jagsi, R.1
  • 4
    • 79251470391 scopus 로고    scopus 로고
    • Projections of the cost of cancer care in the United States: 2010 to 2020
    • Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010 to 2020. J Natl Cancer Inst 103:117-128, 2011
    • (2011) J Natl Cancer Inst , vol.103 , pp. 117-128
    • Mariotto, A.B.1    Yabroff, K.R.2    Shao, Y.3
  • 5
    • 80053622483 scopus 로고    scopus 로고
    • National health spending projections through 2020: Economic recovery and reform drive faster spending growth
    • Keehan SP, Sisko AM, Truffer CJ, et al: National health spending projections through 2020: Economic recovery and reform drive faster spending growth. Health Aff (Millwood) 30:1594-1605, 2011
    • (2011) Health Aff (Millwood) , vol.30 , pp. 1594-1605
    • Keehan, S.P.1    Sisko, A.M.2    Truffer, C.J.3
  • 6
    • 84919779430 scopus 로고    scopus 로고
    • Did changes in drug reimbursement after the Medicare modernization act affect chemotherapy prescribing?
    • Hornbrook MC, Malin J, Weeks JC, et al: Did changes in drug reimbursement after the Medicare modernization act affect chemotherapy prescribing? J Clin Oncol 32:4042-4049, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 4042-4049
    • Hornbrook, M.C.1    Malin, J.2    Weeks, J.C.3
  • 7
    • 84919754167 scopus 로고    scopus 로고
    • Payment for cancer care: Time for a new prescription
    • Schnipper LE, Meropol NJ: Payment for cancer care: Time for a new prescription. J Clin Oncol 32:4027-4028, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 4027-4028
    • Schnipper, L.E.1    Meropol, N.J.2
  • 8
    • 68949112230 scopus 로고    scopus 로고
    • American Society of Clinical Oncology: American Society of Clinical Oncology guidance statement: The cost of cancer care
    • Meropol NJ, Schrag D, Smith TJ, et al: American Society of Clinical Oncology: American Society of Clinical Oncology guidance statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 3868-3874
    • Meropol, N.J.1    Schrag, D.2    Smith, T.J.3
  • 9
    • 84919769081 scopus 로고    scopus 로고
    • Debating the oncologist's role in defining the value of cancer care: Our duty is to our patients
    • Sulmasy D, Moy B: Debating the oncologist's role in defining the value of cancer care: Our duty is to our patients. J Clin Oncol 32:4039-4041, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 4039-4041
    • Sulmasy, D.1    Moy, B.2
  • 10
    • 84874582441 scopus 로고    scopus 로고
    • A common theme among ethical issues in oncology: The need to individualize advanced cancer care
    • 102
    • Peppercorn J: A common theme among ethical issues in oncology: The need to individualize advanced cancer care. Oncology (Williston Park) 27:97, 102, 2013
    • (2013) Oncology (Williston Park) , vol.27 , pp. 97
    • Peppercorn, J.1
  • 11
    • 84874631714 scopus 로고    scopus 로고
    • The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
    • Zafar SY, Peppercorn JM, Schrag D, et al: The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 18:381-390, 2013
    • (2013) Oncologist , vol.18 , pp. 381-390
    • Zafar, S.Y.1    Peppercorn, J.M.2    Schrag, D.3
  • 12
    • 84908548883 scopus 로고    scopus 로고
    • Patient experience and attitudes toward addressing the cost of breast cancer care
    • Irwin B, Kimmick G, Altomare I, et al: Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist 19:1135-1140, 2014
    • (2014) Oncologist , vol.19 , pp. 1135-1140
    • Irwin, B.1    Kimmick, G.2    Altomare, I.3
  • 13
    • 33846994727 scopus 로고    scopus 로고
    • Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey
    • Schrag D, Hanger M: Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey. J Clin Oncol 25:233-237, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 233-237
    • Schrag, D.1    Hanger, M.2
  • 14
    • 77957956574 scopus 로고    scopus 로고
    • Continental divide? The attitudes of US and Canadian oncologists on the costs, cost effectiveness, and health policies associated with new cancer drugs
    • Berry SR, Bell CM, Ubel PA, et al: Continental divide? The attitudes of US and Canadian oncologists on the costs, cost effectiveness, and health policies associated with new cancer drugs. J Clin Oncol 28:4149-4153, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 4149-4153
    • Berry, S.R.1    Bell, C.M.2    Ubel, P.A.3
  • 15
    • 34548083941 scopus 로고    scopus 로고
    • Cost issues in new disease-modifying treatments for advanced cancer: In-depth interviews with physicians
    • de Kort SJ, Kenny N, van Dijk P, et al: Cost issues in new disease-modifying treatments for advanced cancer: In-depth interviews with physicians. Eur J Cancer 43:1983-1989, 2007
    • (2007) Eur J Cancer , vol.43 , pp. 1983-1989
    • De Kort, S.J.1    Kenny, N.2    Van Dijk, P.3
  • 16
    • 84919359545 scopus 로고    scopus 로고
    • Uptake and costs of hypofractionated versus conventional whole-breast irradiation after breast conserving surgery in the United States, 2008 to 2013
    • Bekelman JE, Sylwestrzak G, Barron J, et al: Uptake and costs of hypofractionated versus conventional whole-breast irradiation after breast conserving surgery in the United States, 2008 to 2013. JAMA 312:2542-2550, 2014
    • (2014) JAMA , vol.312 , pp. 2542-2550
    • Bekelman, J.E.1    Sylwestrzak, G.2    Barron, J.3
  • 17
    • 84868193076 scopus 로고    scopus 로고
    • Cost comparison of radiation treatment options after lumpectomy for breast cancer
    • Greenup RA, Camp MS, Taghian AG, et al: Cost comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol 19:3275-3281, 2012
    • (2012) Ann Surg Oncol , vol.19 , pp. 3275-3281
    • Greenup, R.A.1    Camp, M.S.2    Taghian, A.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.